The clinical cases are to gain an understanding of the diagnosis and management of some of the rarer and more unusual dermatology conditions and unusual presentations of common dermatological problems.
Benefits of attending:
For those attending in person, the clinical cases will be followed by a drinks reception to facilitate networking.
Book to attend this event in person or virtually. To view the rates and agenda, please select your preference below.
Attendance criteria
You can only attend this meeting if you hold a Consultant or training post in dermatology. You must bring ID with you to show this. Exceptions are made for those who are Section members (by completing an additional application form) who have made significant contributions to dermatology and are of good standing in the profession.
This event will be recorded* and all registered delegates will be able to access the recording for 60 days after. The link will be distributed 3 days after the event takes place.
Follow us on:
Facebook
Instagram
LinkedIn
Twitter
YouTube
The Dermatology Section would like to thank our Annual Sponsors AbbVie, Almirall Ltd, Bristol Myers Squibb, Eucerin, Incyte, La Roche-Posay & Cerave, Lilly, Pfizer, Regeneron, Sanofi and UCB Pharma Ltd for their valued support of the 2024 to 2025 Academic Programme. We would also like to thank our sponsor Johnson & Johnson Innovative Medicine for their support of this meeting.
Please note that none of the companies listed has had any influence or involvement over the agenda, content or organisation of the meetings.
Standard pricing available until 21 December 2024.
| RSM Trainee | RSM Fellow |
|---|---|
| £0.00 | £0.00 |
| Consultant / GP / SAS Doctors | Trainee |
|---|---|
| £84.00 | £50.00 |
Standard pricing available until 20 December 2024.
| RSM Fellow | RSM Trainee |
|---|---|
| £0.00 | £0.00 |
| Consultant / GP / SAS Doctors | Trainee |
|---|---|
| £80.00 | £47.00 |
Dr Anshoo Sahota, President, Dermatology Section, Royal Society of Medicine
Dr Emily House, Dermatology Clinical Fellow, Barts Health NHS Trust on behalf of Dr Anna Chapman, Consultant Dermatologist, Barts Health NHS Trust
Dr Raunak Rajesh Modak, Clinical Fellow, Barts Health NHS Trust on behalf of Dr Ravinder Kaur Atkar, Consultant Dermatologist, and Dr Sarah Helen Mehrtens, Consultant Dermatologist, Barts Health NHS Trust
Dr Geoffrey Hanley, Dermatology Registrar, Beaumont Hospital, Dublin on behalf of Dr Karen Eustace, Consultant Dermatologist, Beaumont Hospital, Dublin
Dr Zhenghao Wang, Clinical Fellow, Norfolk and Norwich University Hospitals NHS Foundation Trust on behalf of Dr Bo Liu, SAS Doctor, and Dr Ava Lee, Consultant Dermatologist, Norfolk and Norwich University Hospitals NHS Foundation Trust
Live stream:
Sponsored industry presentation by Incyte
Opzelura: Now you can put vitiligo in the spotlight video
Sponsored industry presentation by Almirall Ltd
EBGLYSS ▼(lebrikiziumab) clinical data: What do the trials show
Dr Sara O’Kelly, Specialty Trainee Year 4 Registrar, East Kent Hospitals University NHS Foundation Trust on behalf of Dr Saul Halpern, Consultant Dermatologist, Dr Andrew Birnie, Consultant Dermatologist, Dr Asha Rajeev, Consultant Dermatologist, and Dr Konstantinos Skendros, Consultant Histopathologist, East Kent Hospitals University NHS Foundation Trust
Dr Evangelos Christou, Dermatology Speciality Trainee Year 4, Specialty Registrar, Ninewells Hospital and Medical School, Dundee on behalf of Dr Andrew Affleck, Consultant Dermatologist, Ninewells Hospital and Medical School, Dundee
Dr Conn McGrath, Dermatology Specialty Trainee Year 3, Barts Health NHS Trust on behalf of Prof Anthony Bewley, Consultant Dermatologist, and Dr Maria Angeliki Gkini, Consultant Dermatologist, Barts Health NHS Trust
Dr Janine Dewar, Dermatology Clinical Fellow, St George's University Hospitals NHS Foundation Trust on behalf of Dr Bernard Ho, Consultant Dermatologist, St George's University Hospitals NHS Foundation Trust
Dr Anshoo Sahota, President, Dermatology Section, Royal Society of Medicine
Dr Emily House, Dermatology Clinical Fellow, Barts Health NHS Trust on behalf of Dr Anna Chapman, Consultant Dermatologist, Barts Health NHS Trust
Dr Raunak Rajesh Modak, Clinical Fellow, Barts Health NHS Trust on behalf of Dr Ravinder Kaur Atkar, Consultant Dermatologist, and Dr Sarah Helen Mehrtens, Consultant Dermatologist, Barts Health NHS Trust
Dr Geoffrey Hanley, Dermatology Registrar, Beaumont Hospital, Dublin on behalf of Dr Karen Eustace, Consultant Dermatologist, Beaumont Hospital, Dublin
Dr Zhenghao Wang, Clinical Fellow, Norfolk and Norwich University Hospitals NHS Foundation Trust on behalf of Dr Bo Liu, SAS Doctor, and Dr Ava Lee, Consultant Dermatologist, Norfolk and Norwich University Hospitals NHS Foundation Trust
Live stream:
Sponsored industry presentation by Incyte
Opzelura: Now you can put vitiligo in the spotlight video
Sponsored industry presentation by Almirall Ltd
EBGLYSS ▼(lebrikiziumab) clinical data: What do the trials show
Dr Sara O’Kelly, Specialty Trainee Year 4 Registrar, East Kent Hospitals University NHS Foundation Trust on behalf of Dr Saul Halpern, Consultant Dermatologist, Dr Andrew Birnie, Consultant Dermatologist, Dr Asha Rajeev, Consultant Dermatologist, and Dr Konstantinos Skendros, Consultant Histopathologist, East Kent Hospitals University NHS Foundation Trust
Dr Evangelos Christou, Dermatology Speciality Trainee Year 4, Specialty Registrar, Ninewells Hospital and Medical School, Dundee on behalf of Dr Andrew Affleck, Consultant Dermatologist, Ninewells Hospital and Medical School, Dundee
Dr Conn McGrath, Dermatology Specialty Trainee Year 3, Barts Health NHS Trust on behalf of Prof Anthony Bewley, Consultant Dermatologist, and Dr Maria Angeliki Gkini, Consultant Dermatologist, Barts Health NHS Trust
Dr Janine Dewar, Dermatology Clinical Fellow, St George's University Hospitals NHS Foundation Trust on behalf of Dr Bernard Ho, Consultant Dermatologist, St George's University Hospitals NHS Foundation Trust
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
Registration for this event will close at 1:00am on Wednesday 18 December 2024. Late registrations will not be accepted.
The agenda is subject to change at any time
If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenter’s and RSM discretion.
All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.
This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.
